Authors:
ANLAUF M
BAUMGART P
FRANZ I
GOTZEN R
KRONIG B
MEYERSABELLEK W
MIDDEKE M
SCHRADER J
SCHULTE KL
WEBER F
Citation: M. Anlauf et al., STATEMENT ON AMBULATORY BLOOD-PRESSURE MONITORING BY THE GERMAN-HYPERTENSION-LEAGUE, Journal of human hypertension, 9(9), 1995, pp. 777-779
Authors:
SCHRODER R
WEGSCHEIDER K
SCHRODER K
DISSMANN R
MEYERSABELLEK W
Citation: R. Schroder et al., EXTENT OF EARLY ST SEGMENT ELEVATION RESOLUTION - A STRONG PREDICTOR OF OUTCOME IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION AND A SENSITIVE MEASURE TO COMPARE THROMBOLYTIC REGIMENS - A SUBSTUDY OF THE INTERNATIONAL JOINT EFFICACY COMPARISON OF THROMBOLYTICS (INJECT) TRIAL, Journal of the American College of Cardiology, 26(7), 1995, pp. 1657-1664
Authors:
DEETJEN A
HEIDLAND A
PANGERL A
MEYERSABELLEK W
SCHAEFER RM
Citation: A. Deetjen et al., ANTIHYPERTENSIVE TREATMENT WITH A VASODILATING BETA-BLOCKER, CARVEDILOL, IN CHRONIC-HEMODIALYSIS PATIENTS, Clinical nephrology, 43(1), 1995, pp. 47-52
Authors:
HAMPTON JR
SCHRODER R
WILCOX RG
SKENE AM
MEYERSABELLEK W
HEIKKILA J
MOLLER B
OSTOR E
SADOWSKI Z
SCHAFER H
STEPINSKA I
BOHM E
FOXLEY A
PFARR E
SCHIRMER G
WALTHER K
Citation: Jr. Hampton et al., RANDOMIZED, DOUBLE-BLIND COMPARISON OF RETEPLASE DOUBLE-BOLUS ADMINISTRATION WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION (INJECT) - TRIAL TO INVESTIGATE EQUIVALENCE, Lancet, 346(8971), 1995, pp. 329-336
Authors:
KULT J
BOESKEN W
KUHN A
MEYERSABELLEK W
PIESCHE L
Citation: J. Kult et al., SHORT-TERM HIGH-DOSE INTRAVENOUS TREATMENT WITH THE NEW LOOP DIURETICTORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Kidney international, 47(3), 1995, pp. 992-992
Authors:
BOESKEN W
KULT J
KUHN A
MEYERSABELLEK W
PIESCHE L
VANDERDOES R
Citation: W. Boesken et al., LONG-TERM SAFETY OF HIGH-DOSE ORAL TREATMENT WITH THE NEW LOOP DIURETIC TORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Kidney international, 47(3), 1995, pp. 992-992
Authors:
ANLAUF M
BAUMGART P
FRANZ I
GOTZEN R
KRONIG B
MEYERSABELLEK W
MIDDEKE M
SCHRADER J
SCHULTE KL
WEBER F
Citation: M. Anlauf et al., RECOMMENDATIONS OF THE DEUTSCHE-LIGA-ZUR- BEKAMPFUNG-DES-HOHEN-BLUTDRUCKES-EV - CONTINUOUS AMBULATORY BLOOD-PRESSURE MONITORING, Herz, Kreislauf, 27(4), 1995, pp. 3-6
Authors:
NEUHAUS KL
VONESSEN R
VOGT A
TEBBE U
RUSTIGE J
WAGNER HJ
APPEL KF
STIENEN U
KONIG R
MEYERSABELLEK W
Citation: Kl. Neuhaus et al., DOSE-FINDING WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM-06.022) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE GERMAN RECOMBINANT PLASMINOGEN-ACTIVATOR STUDY, Journal of the American College of Cardiology, 24(1), 1994, pp. 55-60
Authors:
SCHULTE KL
LIEDERWALD K
MEYERSABELLEK W
VANGEMMEREN D
LENZ T
GOTZEN R
Citation: Kl. Schulte et al., RELATIONSHIPS BETWEEN AMBULATORY BLOOD-PRESSURE, FOREARM VASCULAR-RESISTANCE, AND LEFT-VENTRICULAR MASS IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS, American journal of hypertension, 6(9), 1993, pp. 786-793
Authors:
BODE C
SMALLING RW
SEN S
KALBFLEISCH J
BOEHM E
ODENHEIMER DJ
MEYERSABELLEK W
Citation: C. Bode et al., RECOMBINANT PLASMINOGEN-ACTIVATOR ANGIOGRAPHIC PHASE-II INTERNATIONALDOSE-FINDING STUDY (RAPID) - PATENCY ANALYSIS AND MORTALITY END-POINTS, Circulation, 88(4), 1993, pp. 292-292
Authors:
TEBBE U
VONESSEN R
SMOLARZ A
LIMBOURG P
ROX J
RUSTIGE J
VOGT A
WAGNER J
MEYERSABELLEK W
NEUHAUS KL
Citation: U. Tebbe et al., OPEN, NONCONTROLLED DOSE-FINDING STUDY WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM 06.022) GIVEN AS A DOUBLE BOLUS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 72(7), 1993, pp. 518-524